Resectable Lung Non-Small Cell Carcinoma clinical trials at UCSD

1 research study open to eligible people

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
open to eligible people ages 18 years and up
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
La Jolla, California and other locations

Our lead scientists for Resectable Lung Non-Small Cell Carcinoma research studies include Lyudmila A. Bazhenova.

Last updated: June 21, 2022

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)